SpringWorks Therapeutics, Inc. (SWTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.68B |
| Enterprise Value | 2.62B |
| P/E Ratio | -13.5 |
| PEG Ratio | -0.34 |
| Price/Sales Ratio | 18.48 |
| Price/Book Ratio | 7.24 |
| Enterprise/Revenue | 18.16 |
| Enterprise/EBITDA | -12.67 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
| Profit Margin | -1.35 |
| Operating Margin | -1.45 |
| Return On Assets | -0.44 |
| Return On Equity | -0.47 |
| Revenue | 191.59M |
| Revenue/Share | 2.58 |
| Gross Profit | 179.04M |
| EBITDA | -274.66M |
| Net Income | -258.13M |
| Diluted EPS | -3.48 |
| Total Cash | 287.87M |
| Total Cash/Share | 4.15 |
| Total Debt | 7.39M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 3.81 |
| Book Value Per Share | 6.49 |
| 52-Week Change | 30.85 |
| 52-Week High | 62 |
| 52-Week Low | 28.21 |
| Moving Average 50 Days | 45.88 |
| Moving Average 200 Days | 41.19 |
| Average Volume | 5.85M |
| Shares Outstanding | 75.35M |
| % Held by Institutions | 100.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |